Daridorexant (Act-541468), a new dual orexin receptor antagonist, for the treatment of insomnia disorder: a randomized, double-blind, placebo-controlled, active-reference phase 2 study

Authors
Category Primary study
JournalSleep Medicine
Year 2019
This article has no abstract
Epistemonikos ID: cc9460fd22aea0cf7c2666caaa5fe2869f7404b7
First added on: Feb 11, 2025